Concepedia

Publication | Open Access

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

DOIFull Paper Access

46

Citations

63

References

2024

Year

James J. Hartman, Darren T. Hwee, Julien Robert‐Paganin, Chih-Yuan Chuang, Eva R. Chin, Samantha Edell, Ken H. Lee, Roshni Madhvani, Preeti Paliwal, Julien Pernier,
Nature Cardiovascular Research

References

YearCitations

Page 1